Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07328698

Postoperative Ozonated Oil Dressing After Open Inguinal Hernia Repair: A Randomized Pilot Trial

Led by Nigde Omer Halisdemir University · Updated on 2026-02-11

60

Participants Needed

1

Research Sites

15 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study looks at whether a special wound dressing containing ozonated oil can reduce early wound inflammation after open inguinal hernia surgery. Open inguinal hernia repair is a common operation, and although infection rates are low, many patients experience redness, swelling, tenderness, or discomfort at the surgical site during the first days after surgery. Participants undergoing elective open inguinal hernia repair will be randomly assigned to receive either an ozonated oil-impregnated dressing or a standard sterile dressing after the operation. The main outcome is the level of wound inflammation measured on the third day after surgery. Other outcomes include wound temperature, pain levels, cosmetic healing, and wound-related problems during the first 30 days. The ozonated oil used in this study is a CE-certified medical product that is already used in routine wound care. This pilot study aims to provide preliminary data to help determine whether ozonated oil dressing may improve early wound healing compared with standard care.

CONDITIONS

Official Title

Postoperative Ozonated Oil Dressing After Open Inguinal Hernia Repair: A Randomized Pilot Trial

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 75 years
  • ASA physical status I-III
  • Scheduled for elective, unilateral open inguinal hernia repair
  • Able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Emergency inguinal hernia (incarcerated or strangulated)
  • Recurrent inguinal hernia
  • Concomitant surgical procedures during the same operation
  • Immunosuppression or long-term systemic steroid use
  • Use of anticoagulant or antiplatelet therapy
  • Known bleeding disorders
  • Active dermatologic disease at the surgical incision site
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dr. Ali Rıza Erdoğan Private Practice Office

Niğde, Niğde Province, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

A

Ali Rıza Erdoğan, Medical doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here